Cite
HARVARD Citation
Palau, P. et al. (2022). Short‐term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA‐VO2): a randomized clinical trial. European journal of heart failure. pp. 1816-1826. [Online].